⌘+K

January 1, 2023Health Evaluation and PromotionOpen Access

Obesity, atherosclerotic risk factors, and metabolic syndrome in vascular aging and treatment in the elderly

View Full Paper

Ask AI

Bookmark

Share

Why the study?

To clarify the involvement of obesity, atherosclerotic risk factors, and metabolic syndrome in vascular aging in the elderly population and examine the significance of atherosclerotic risk factor treatment.

Key Points

To determine how obesity, atherosclerotic risk factors, and metabolic syndrome drive vascular aging in older populations, while evaluating the therapeutic importance of risk factor management.
Evaluated the impact of metabolic syndrome, excess adiposity, and atherosclerotic risk factors on vascular aging mechanisms in elderly populations.
Assessed clinical approaches and therapeutic interventions directed toward modifying atherosclerotic risk factors.
Identified metabolic syndrome and related atherosclerotic factors as key contributors accelerating arterial stiffening and vascular aging in older individuals.
Underscored that proactive management and targeted treatment of cardiovascular risk factors remain clinically critical for preserving vascular health in late life.

Population

Elderly population

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Hypothesis-generating for metabolic factors in elderly vascular aging; prospective trials needed before guiding treatment.

Abstract

Objectives: To clarify the involvement of obesity, atherosclerotic risk factors, and metabolic syndrome in vascular aging in the elderly population and examine the significance of atherosclerotic risk factor treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yamanouchi et al. (2023) studied this question.

synapsesocial.com/papers/6a815a4f0fbd199afca8c622 https://doi.org/10.7143/jhep.2021-33

View Full Paper

Ask AI

Bookmark

Share